Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-4957
Abstract: Imipridones are first-in-class anti-tumor compounds including ONC201, which has shown promising clinical activity. ONC212 was designed as a second-generation imipridone. We first confirmed the ONC212 effects in a collection of 1,088 human cancer cell lines…
read more here.
Keywords:
imipridone onc212;
onc212;
novel imipridone;
cancer ... See more keywords